Back to Search
Start Over
Cost‐effectiveness analysis of recombinant factor IX Fc fusion protein compared with recombinant factor IX for the treatment of moderate–severe to severe hemophilia B in China
- Source :
- Pediatric Blood & Cancer. 70
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
- Subjects :
- Oncology
Pediatrics, Perinatology and Child Health
Hematology
Subjects
Details
- ISSN :
- 15455017 and 15455009
- Volume :
- 70
- Database :
- OpenAIRE
- Journal :
- Pediatric Blood & Cancer
- Accession number :
- edsair.doi...........3f70a9b4fd72b9b3342811f356403044
- Full Text :
- https://doi.org/10.1002/pbc.30264